Literature DB >> 17191126

Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro.

Paul B S Lai1, Tian-Yi Chi, George G Chen.   

Abstract

Induction of p53 gene expression in cancer cells can lead to both cell cycle arrest and apoptosis. To clarify whether the level of p53 expression determines the apoptotic response of hepatocellular carcinoma (HCC) cells, we assessed the effect of various levels of expression of p53 gene on a p53-deficient HCC cell line, Hep3B, utilizing a doxycycline (Dox)-regulated inducible p53 expression system. Our results showed that apoptosis was induced in HCC cells with high levels of p53 expression. However, lower level of p53 expression induced only cell cycle arrest but not apoptosis. Bax expression was up-regulated following high levels of p53 expression, while bcl-2 expression was not altered by the level of p53 expression. Moreover, p21 expression was observed in both high and low expression of p53. These results suggest the level of p53 expression could determine if the HCC cells would go into cell cycle arrest or apoptosis. Bax may participate, at least in part, in inducing p53-dependent apoptosis and the induction of p21 alone was able to cause cell cycle arrest but not apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17191126     DOI: 10.1007/s10495-006-0571-1

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  28 in total

Review 1.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

2.  Apoptotic effects of dipyrido [3,2-a:2',3'-c] phenazine (dppz) Au(III) complex against diethylnitrosamine/phenobarbital induced experimental hepatocarcinogenesis in rats.

Authors:  Neslihan Tekin; Mehmet C Ustuner; Fahrettin Akyuz; Cansu S Ozbayer; Ozlem Aydın; Kadriye Benkli; Dilek Burukoglu; Irfan Degirmenci; Hilmi Ozden
Journal:  Mol Biol Rep       Date:  2014-04-23       Impact factor: 2.316

3.  Clinical and biological significance of never in mitosis gene A-related kinase 6 (NEK6) expression in hepatic cell cancer.

Authors:  Xiaolei Cao; Yunfei Xia; Junling Yang; Jinxia Jiang; Li Chen; Runzhou Ni; Liren Li; Zhifeng Gu
Journal:  Pathol Oncol Res       Date:  2011-07-05       Impact factor: 3.201

4.  Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis.

Authors:  C Nadalutti; K M Viiri; K Kaukinen; M Mäki; K Lindfors
Journal:  Cell Prolif       Date:  2011-02       Impact factor: 6.831

5.  TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis.

Authors:  Ya-nan Ji; Qin Wang; Jun Xue
Journal:  Tumour Biol       Date:  2014-02

Review 6.  Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.

Authors:  Jiangbo Liu; Qingyong Ma; Min Zhang; Xinshuai Wang; Dong Zhang; Wei Li; Fengfei Wang; Erxi Wu
Journal:  Eur J Cancer       Date:  2012-03-27       Impact factor: 9.162

7.  Induction of S phase arrest and apoptosis by ethyl acetate extract from Tetrastigma hemsleyanum in human hepatoma HepG2 cells.

Authors:  Xin Peng; Ding-ding Zhuang; Qiao-sheng Guo
Journal:  Tumour Biol       Date:  2015-01-18

8.  TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis.

Authors:  Ping Zhan; Ya-Nan Ji; Li-Ke Yu
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

9.  ZBP-89 reduces the cell death threshold in hepatocellular carcinoma cells by increasing caspase-6 and S phase cell cycle arrest.

Authors:  George G Chen; Ursula P F Chan; Long-Chuan Bai; King Yip Fung; Art Tessier; Ann K Y To; Juanita L Merchant; Paul B S Lai
Journal:  Cancer Lett       Date:  2009-04-11       Impact factor: 8.679

10.  Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis.

Authors:  Ping Zhan; Ya-Nan Ji
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.